2022
DOI: 10.1007/978-1-0716-2863-8_18
|View full text |Cite
|
Sign up to set email alerts
|

Combination of Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Substrate Trapping for the Detection of Transient Protein Interactions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…In order to consider HDACs as a therapeutic target in HGSOC we need to better understand their function in HGSOC, including their protein–protein interactions. Applying a catalytically inactive mutant allows substrates to bind to enzymes for a longer period of time and enables the detection of interacting proteins, including transient interactors, using immunoprecipitation coupled with mass spectrometry analysis, as described previously. Mass spectrometry-basedanalysis can facilitate a comprehensive understanding of the HGSOC proteome, thereby enabling the elucidation of functional consequences of genomic changes . This analytical approach can also enable the identification of new therapeutic vulnerabilities to decrease drug resistance.…”
mentioning
confidence: 99%
“…In order to consider HDACs as a therapeutic target in HGSOC we need to better understand their function in HGSOC, including their protein–protein interactions. Applying a catalytically inactive mutant allows substrates to bind to enzymes for a longer period of time and enables the detection of interacting proteins, including transient interactors, using immunoprecipitation coupled with mass spectrometry analysis, as described previously. Mass spectrometry-basedanalysis can facilitate a comprehensive understanding of the HGSOC proteome, thereby enabling the elucidation of functional consequences of genomic changes . This analytical approach can also enable the identification of new therapeutic vulnerabilities to decrease drug resistance.…”
mentioning
confidence: 99%